D. E. Shaw & Co »

Aeglea Biotherapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.3M 27k 88.78

More positions owned by D. E. Shaw & Co

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices Put Option (AMD)
Amazon (AMZN)
Micron Technology Put Option (MU)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Bloom Energy Corp Com Cl A Put Option (BE)
Crowdstrike Hldgs Cl A Put Option (CRWD)
Sandisk Corp (SNDK)

View all positions for D. E. Shaw & Co

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Perceptive Advisors
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Capital Management
VR Adviser
Driehaus Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Jupiter Topco
TCG Crossover Management
Tang Capital Management
Bank of America Corporation

View all funds holding Aeglea Biotherapeutics